Lower urinary tract symptoms (LUTS) are a group of clinical symptoms involving the bladder, urinary sphincter, urethra and, in men, the prostate. The term is more commonly applied to menover 40% of older men are affectedbut lower urinary tract symptoms also affect women. The condition is also termed prostatism in men, but LUTS is preferred.

Symptoms and signs

Symptoms can be categorised into:

Filling (storage) or irritative symptoms

• Increased frequency of urination

• Increased urgency of urination

• Urge incontinence

• Excessive passage of urine at night

Voiding or obstructive symptoms

• Poor stream (unimproved by straining)

• Hesitancy (worsened if bladder is very full)

• Terminal dribbling

• Incomplete voiding

• Urinary retention

• Overflow incontinence (occurs in chronic retention)

• Episodes of near retention

As the symptoms are common and non-specific, LUTS is not necessarily a reason to suspect prostate cancer. Large studies of patients have also failed to show any correlation between lower urinary tract symptoms and a specific diagnosis. Also, recently a report of lower urinary tract symptoms even with malignant features in the prostate failed to be associated with prostate cancer after further laboratory investigation of the biopsy.

Causes

• Benign prostatic hyperplasia (BPH)

• Bladder stone

• Cancer of the bladder and prostate

• Detrusor muscle weakness and/or instability

• Diabetes

• Use of ketamine

• Neurological conditions; for example multiple sclerosis, spinal cord injury, cauda equina syndrome

• Prostatitis, including IgG4-related prostatitis

• Urethral stricture

• Urinary tract infections (UTIs)

Diagnosis

The International Prostate Symptom Score (IPSS) can be used to gauge the symptoms, along with physician examination. Other primary and secondary tests are often carried out, such as a prostate-specific antigen (PSA) test, urinalysis, ultrasound, urinary flow studies, imaging, temporary prostatic stent placement, prostate biopsy and cystoscopy.

Treatment

Treatment will depend on the cause, if one is found. For example; with a UTI, a course of antibiotics would be given; appropriate medication would be administered to treat benign prostatic hyperplasia.

Lifestyle changes

Other treatments include lifestyle advice; for example, avoiding dehydration in recurrent cystitis.

Men with prostatic hypertrophy are advised to sit down whilst urinating. A 2014 meta-analysis found that, for elderly males with LUTS, sitting to urinate meant there was a decrease in post-void residual volume (PVR, ml), increased maximum urinary flow (Qmax, ml/s), which is comparable with pharmacological intervention, and decreased the voiding time (VT, s). The improved urodynamic profile is related to a lower risk of urologic complications, such as cystitis and bladder stones.

Physical activity

Physical activity has been recommended as a treatment for urinary tract symptoms. A 2019 Cochrane review of six studies involving 652 men assessing the effects of physical activity alone, physical activity as a part of a self-management program, among others. The evidence from this review states that there are important uncertainties whether physical activity is helpful in men experiencing urinary symptoms caused by benign prostatic hyperplasia.

Medications

With benign prostatic enlargement causes of LUTS, people may be offered a variety of medications (as a single drug or combining them) when there are persistent moderate symptoms:

• Alpha blockers

• 5-alpha reductase inhibitors

• Phosphodiesterase inhibitors

• Muscarinic receptor antagonists

• Plants extracts (phytotherapy)

• Beta-3 agonist

Surgical treatment

Surgical treatment of LUTS can include:

• Ablation procedures – used in treating both bladder tumours and bladder outlet obstruction, such as prostate conditions.

• Bladder-neck incision (BNI)

• Removal of the prostate – open, robotic, and endoscopic techniques are used.

• Stenting of the prostate and urethra.

• Transurethral resection of the prostate (TURP)

• Transurethral microwave thermotherapy

• Urethral dilatation, a common treatment for strictures.

Epidemiology

• Prevalence increases with age. The prevalence of nocturia in older men is about 78%. Older men have a higher incidence of LUTS than older women.

• Around one third of men will develop urinary tract (outflow) symptoms, of which the principal underlying cause is benign prostatic hyperplasia.

• Once symptoms arise, their progress is variable and unpredictable with about one third of patients improving, one third remaining stable and one third deteriorating.

See also

• Benign prostatic hyperplasia

• Salvia miltiorrhiza

• Saw palmetto

• Phytotherapy

References

Further reading

• NHS; Cancer Screening Programmes. Prostate Cancer Risk Management.

External links

• LUTS in men – Patient.info

• LUTS in women – Patient.info